Across TCGA pan-cancer cohorts, LRRC14B mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LRRC14B data layer compared with 23 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher LRRC14B mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated LRRC14B expression acts as an unfavorable survival marker, although some lineages such as CCRCC show a favorable association.

CCRCC are the cancer types where LRRC14B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	IV	0.861	0.131	.017	10	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: LRRC14B tumor-vs-normal RNA expression · all LRRC14B data types